Universitat Autònoma de Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (5)

2015

  1. Critical analysis of the stringent complete response in multiple myeloma: Contribution of sFLC and bone marrow clonality

    Blood, Vol. 126, Núm. 7, pp. 858-862

2013

  1. Intravenous Busulfan and Melphalan as a Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma: A Matched Comparison to a Melphalan-Only Approach

    Biology of Blood and Marrow Transplantation, Vol. 19, Núm. 1, pp. 69-74

2005

  1. Reduced-intensity conditioning allogeneic blood stem cell transplantation with fludarabine and oral busulfan with or without pharmacokinetically targeted busulfan dosing in patients with myeloid leukemia ineligible for conventional conditioning

    Biology of Blood and Marrow Transplantation, Vol. 11, Núm. 6, pp. 437-447

2003

  1. Multicolor flourescence in situ hybridization studies in multiple myeloma and monoclonal gammopathy of undetermined significance

    Hematology Journal, Vol. 4, Núm. 1, pp. 67-70

1988

  1. Treatment of high-risk acute lymphoblastic leukemia with protocols PETHEMA LAL 7/78 and LAL 17/84

    Anales Espanoles de Pediatria, Vol. 29, Núm. SUPPL. 34, pp. 72-83